Vascular Dynamics
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$13.5m | Late VC | ||
N/A | $9.7m | Series A | |
$16.9m | Series B | ||
N/A | $10.4m | Series C | |
N/A | $394k | Convertible | |
N/A | $985k | Convertible | |
N/A | $33.1m | Growth Equity VC | |
* | $20.0m | Late VC | |
Total Funding | AUD162m |
Recent News about Vascular Dynamics
EditVascular Dynamics Inc. is a pioneering medical device company focused on developing innovative solutions for the treatment of hypertension. The company operates in the medical technology market, specifically targeting patients who are resistant to conventional hypertension treatments. Vascular Dynamics' core product, the MobiusHD System, is an endovascular device designed to amplify the body's natural baroreflex response. This minimally invasive procedure aims to stimulate vasodilation, reduce heart rate, and modulate kidney response, thereby decreasing blood pressure. The company primarily serves healthcare providers and patients, offering a cutting-edge alternative to traditional hypertension therapies. Vascular Dynamics generates revenue through the sale and distribution of its MobiusHD System, which has received a CE mark, indicating compliance with European health, safety, and environmental protection standards. The business model focuses on leveraging advanced medical technology to improve patient outcomes and expand market reach through clinical validation and regulatory approvals.
Keywords: hypertension, endovascular, MobiusHD, baroreflex, vasodilation, medical device, minimally invasive, CE mark, patient outcomes, healthcare providers.